Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxygen Therapy for Fatigue in Hypermobile EDS
NCT04890431Phase 4Unknown
- Sponsor
- Hôpital Saint Joseph Marseille
- Start
- Mar 2022
- Primary completion
- Oct 2023
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
A Phase 4 trial of oxygen in hypermobile Ehlers-Danlos syndrome (hEDS), sponsored by Hôpital Saint Joseph Marseille. Status: unknown.
02
Drugs
oxygen
03
Conditions
hypermobile Ehlers-Danlos syndrome (hEDS)
Beyond the preview
Go deeper on NCT04890431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04890431.